Kita‐Kyushu lung cancer antigen‐1 (KK‐LC‐1), also known as CT83 or cxorf61, is highly expressed in lung cancer, gastric cancer, and breast cancer, and its role in immunotherapy needs to be further explored [60]. Here, CT83 is linked to breast carcinoma.